
Pfizer, Inc. (NYSE:PFE) is upping its commitment to manufacture its oral COVID-19 pill Paxlovid in the United States.
What Happened: Pfizer will invest an incremental $120 million at its Kalamazoo, Michigan facility to augment production of Paxlovid, the pharma giant said in a statement late Monday.